NEK2 elevation may be associated with poor prognosis in ccRCC, and NEK2 enhances ccRCC cell proliferation, migration, and invasion ability by activating the WNT/β-catenin signaling pathway. The gene discussed is NEK2; the disease is nonpapillary renal cell carcinoma.